• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close and Host Conference Call

    3/11/25 7:00:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials
    Get the next $CBUS alert in real time by email

    SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report fourth quarter 2024 financial results on Thursday, March 20, 2025. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates.

    Title: Cibus, Inc. Fourth Quarter 2024 Results Conference Call

    Event Date: Thursday, March 20, 2025        

    Time: 4:30 p.m. ET        

    Participant Numbers: +1-877-300-8521 (U.S.), +1-412-317-6026 (International)        

    Event Link: https://investor.cibus.com/events

    For interested individuals unable to join the conference call, a dial-in replay of the call will be available through Thursday, April 3, 2025 and can be accessed by dialing +1-844-512-2921 (U.S.), +1-412-317-6671 (International) and entering replay passcode: 10196898.

    A live audio webcast of the call, along with accompanying slides, will be available under "News & Events" in the Investor section of the Company's website, investor.cibus.com. An archived webcast will be available on the Company's website for 90 days after the event.

    About Cibus

    Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop and license traits to seed companies in exchange for royalties on seed sales. Cibus' long-term focus is productivity traits for farmers for the major global row crops with large acreage such as canola, corn, rice, soybean, and wheat. Cibus is a technology leader in high-throughput gene editing technology that is expected to enable it to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus has developed a current pipeline of five productivity traits including important traits for weed management in Rice, Pod Shatter Reduction, and Sclerotinia (disease) resistance, which are its near-term focus.

    Cibus Contacts:

    Investor Relations

    Karen Troeber

    [email protected]

    858-450-2636

    Jeff Sonnek – ICR

    [email protected]

    Media Relations

    Colin Sanford

    [email protected]

    203-918-4347



    Primary Logo

    Get the next $CBUS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CBUS

    DatePrice TargetRatingAnalyst
    7/29/2024$25.00Buy
    Alliance Global Partners
    7/19/2024$22.00Buy
    Canaccord Genuity
    10/9/2023$25.00Buy
    H.C. Wainwright
    7/19/2023$30.00Buy
    Canaccord Genuity
    More analyst ratings

    $CBUS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Box Kimberly Ann

    4 - Cibus, Inc. (0001705843) (Issuer)

    9/26/25 9:30:15 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    New insider Box Kimberly Ann claimed no ownership of stock in the company (SEC Form 3)

    3 - Cibus, Inc. (0001705843) (Issuer)

    9/26/25 9:24:34 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Director Riggs Rory B exercised 4,050,000 in-the-money shares at a strike of $0.00, increasing direct ownership by 38% to 14,583,307 units (SEC Form 4)

    4 - Cibus, Inc. (0001705843) (Issuer)

    6/11/25 5:11:05 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alliance Global Partners initiated coverage on Cibus Global with a new price target

    Alliance Global Partners initiated coverage of Cibus Global with a rating of Buy and set a new price target of $25.00

    7/29/24 7:49:52 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Canaccord Genuity resumed coverage on Cibus Global with a new price target

    Canaccord Genuity resumed coverage of Cibus Global with a rating of Buy and set a new price target of $22.00

    7/19/24 8:34:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    H.C. Wainwright initiated coverage on Cibus Global with a new price target

    H.C. Wainwright initiated coverage of Cibus Global with a rating of Buy and set a new price target of $25.00

    10/9/23 8:32:05 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cibus Announces the Election of Kimberly A. Box to Board of Directors

    SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ: CBUS), a leading agricultural technology company developing and licensing advanced plant traits that enable higher yields, lower input costs, and more sustainable farming, today announced the election of Kimberly A. Box to its Board of Directors. "Kim brings to Cibus extensive leadership experience in technology and commercialization that will be invaluable as we sharpen our strategic commercialization efforts," said Mark Finn, Cibus Chairman. "Her understanding of market dynamics and experience in guiding innovation into scalable businesses will strengthen our strategic governance as we continue to drive long-term value c

    9/25/25 4:05:00 PM ET
    $CBUS
    $MGRC
    Agricultural Chemicals
    Industrials
    Diversified Commercial Services
    Consumer Discretionary

    Cibus CEO to Highlight Gene Editing's Role in Building Resilient Agriculture at UN Climate Week 2025

    SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced that Peter Beetham, Co-Founder, President, and Interim Chief Executive Officer, will participate in a featured panel during UN Climate Week 2025 in New York City. The event, titled "Investing in a Resilient Future: Innovation, Data & Capital for Energy, Food, Water, and Climate Solutions", supported by Syntax Data, will be held on Tuesday, September 23rd at Midtown Loft, New York City, with a livestream available via LinkedIn. Dr. Beetham will join leaders from the United Nations Devel

    9/22/25 12:10:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus Enters into Agreement with the Latin American Rice Hybrid Consortium to Provide Cibus' Herbicide Tolerance Trait

    Cibus and Centro Internacional de Agricultura Tropical (CIAT) have entered into an agreement to introduce Cibus' proprietary herbicide tolerance trait into elite rice germplasm for Latin America Agreement represents another significant milestone as Cibus aims to bring Latin America rice growers new solutions for advanced weed management in Rice crops SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced a material transfer agreement with Centro Internacional de Agricultura Tropical (CIAT), an organization which, in collaboration with the L

    8/28/25 7:00:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    SEC Filings

    View All

    SEC Form 8-K filed by Cibus Inc.

    8-K - Cibus, Inc. (0001705843) (Filer)

    9/23/25 4:17:55 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    SEC Form 8-K filed by Cibus Inc.

    8-K - Cibus, Inc. (0001705843) (Filer)

    9/16/25 4:07:49 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Cibus Inc.

    SCHEDULE 13G/A - Cibus, Inc. (0001705843) (Subject)

    8/14/25 8:59:40 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Leadership Updates

    Live Leadership Updates

    View All

    Cibus Announces the Election of Kimberly A. Box to Board of Directors

    SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ: CBUS), a leading agricultural technology company developing and licensing advanced plant traits that enable higher yields, lower input costs, and more sustainable farming, today announced the election of Kimberly A. Box to its Board of Directors. "Kim brings to Cibus extensive leadership experience in technology and commercialization that will be invaluable as we sharpen our strategic commercialization efforts," said Mark Finn, Cibus Chairman. "Her understanding of market dynamics and experience in guiding innovation into scalable businesses will strengthen our strategic governance as we continue to drive long-term value c

    9/25/25 4:05:00 PM ET
    $CBUS
    $MGRC
    Agricultural Chemicals
    Industrials
    Diversified Commercial Services
    Consumer Discretionary

    Cibus CEO to Highlight Gene Editing's Role in Building Resilient Agriculture at UN Climate Week 2025

    SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced that Peter Beetham, Co-Founder, President, and Interim Chief Executive Officer, will participate in a featured panel during UN Climate Week 2025 in New York City. The event, titled "Investing in a Resilient Future: Innovation, Data & Capital for Energy, Food, Water, and Climate Solutions", supported by Syntax Data, will be held on Tuesday, September 23rd at Midtown Loft, New York City, with a livestream available via LinkedIn. Dr. Beetham will join leaders from the United Nations Devel

    9/22/25 12:10:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer

    EMERYVILLE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Totus Medicines, a company revolutionizing small molecule drug discovery and development using covalent DNA-encoded libraries and AI tools, today announced the appointment of Simon Harnest, MSc, BSc, as Chief Financial Officer. This key addition comes at a pivotal moment for Totus as the company prepares to advance its clinical-stage program following encouraging results from its Phase 1 study of TOS-358, a covalent PI3Kα inhibitor. "The addition of Simon, with over 15 years' experience in private capital markets strategy and IPO processes, comes at the right time for Totus as we advance our clinical-stage and discovery programs," said

    1/28/25 8:00:00 AM ET
    $CBUS
    $CLLS
    $MGX
    Agricultural Chemicals
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CBUS
    Financials

    Live finance-specific insights

    View All

    Cibus to Report Second Quarter 2025 Financial Results on August 14, 2025 After the Market Close and Host Conference Call

    SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report second quarter 2025 financial results on Thursday, August 14, 2025. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Second Quarter 2025 Results Conference Call Event Date: Thursday, August 14, 2025Time: 4:30 p.m. ETParticipant Numbers: +1-833-316-2483 (U.S.), +1-785-838-9284 (International)The conference ID "CIBUS" or 24287 will be required for en

    8/5/25 7:00:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus Reports First Quarter Financial Results and Provides Year-to-Date Business Update for 2025

    Rice business momentum builds with Cibus' first stacked gene edited herbicide tolerance traits, which the Company believes is an industry first; On track for 2027 targeted commercial launch of HT1 and HT3 traits with customer germplasm integration underway across multiple markets Positive regulatory decision for Cibus' Rice traits HT1 and HT3 in Ecuador; the Ministry of Agriculture and Livestock in Ecuador determined that the Company's HT1 and HT3 Rice traits are equivalent to those developed through conventional breeding Disease resistance program advances with positive Sclerotinia data for multiple modes of action against Sclerotinia in Canola; Cibus' time bound and predictable RTDS tech

    5/8/25 4:05:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus to Report First Quarter 2025 Financial Results on May 8, 2025 After the Market Close and Host Conference Call

    SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report first quarter 2025 financial results on Thursday, May 8, 2025. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. First Quarter 2025 Results Conference Call Event Date: Thursday, May 8, 2025Time: 4:30 p.m. ETParticipant Numbers: +1-833-316-1983 (U.S.), +1-785-838-9310 (International)The c

    4/25/25 7:00:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials